{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:57:57Z","timestamp":1778947077035,"version":"3.51.4"},"reference-count":67,"publisher":"National Institute for Health and Care Research","issue":"67","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/non-commercial-government-licence\/non-commercial-government-licence.htm"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["13\/34\/14"],"award-info":[{"award-number":["13\/34\/14"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journalslibrary.nihr.ac.uk"],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"\n Background<\/jats:title>\n There is good evidence of vaccine effectiveness in healthy individuals but less robust evidence for vaccine effectiveness in the populations targeted for influenza vaccination. The live attenuated influenza vaccine (LAIV) has recently been recommended for children in the UK. The trivalent influenza vaccine (TIV) is recommended for all people aged \u2265\u200965 years and for those aged <\u200965 years who are at an increased risk of complications from influenza infection (e.g. people with asthma).<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To examine the vaccine effectiveness of LAIV and TIV.<\/jats:p>\n <\/jats:sec>\n \n Design<\/jats:title>\n Cohort study and test-negative designs to estimate vaccine effectiveness. A self-case series study to ascertain adverse events associated with vaccination.<\/jats:p>\n <\/jats:sec>\n \n Setting<\/jats:title>\n A national linkage of patient-level general practice (GP) data from 230 Scottish GPs to the Scottish Immunisation & Recall Service, Health Protection Scotland virology database, admissions to Scottish hospitals and the Scottish death register.<\/jats:p>\n <\/jats:sec>\n \n Participants<\/jats:title>\n A total of 1,250,000 people.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n LAIV for 2- to 11-year-olds and TIV for older people (aged \u2265\u200965 years) and those aged <\u200965 years who are at risk of diseases, from 2010\/11 to 2015\/16.<\/jats:p>\n <\/jats:sec>\n \n Main outcome measures<\/jats:title>\n The main outcome measures include vaccine effectiveness against laboratory-confirmed influenza using real-time reverse-transcription polymerase chain reaction (RT-PCR), influenza-related morbidity and mortality, and adverse events associated with vaccination.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Two-fifths (40%) of preschool-aged children and three-fifths (60%) of primary school-aged children registered in study practices were vaccinated. Uptake varied among groups [e.g. most affluent vs. most deprived in 2- to 4-year-olds, odds ratio 1.76, 95% confidence interval (CI) 1.70 to 1.82]. LAIV-adjusted vaccine effectiveness among children (aged 2\u201311 years) for preventing RT-PCR laboratory-confirmed influenza was 21% (95% CI \u201319% to 47%) in 2014\/15 and 58% (95% CI 39% to 71%) in 2015\/16. No significant adverse events were associated with LAIV. Among at-risk 18- to 64-year-olds, significant trivalent influenza vaccine effectiveness was found for four of the six seasons, with the highest vaccine effectiveness in 2010\/11 (53%, 95% CI 21% to 72%). The seasons with non-significant vaccine effectiveness had low levels of circulating influenza virus (2011\/12, 5%; 2013\/14, 9%). Among those people aged \u2265\u200965 years, TIV effectiveness was positive in all six seasons, but in only one of the six seasons (2013\/14) was significance achieved (57%, 95% CI 20% to 76%).<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The study found that LAIV was safe and effective in decreasing RT-PCR-confirmed influenza in children. TIV was safe and significantly effective in most seasons for 18- to 64-year-olds, with positive vaccine effectiveness in most seasons for those people aged \u2265\u200965 years (although this was significant in only one season).<\/jats:p>\n <\/jats:sec>\n \n Future work<\/jats:title>\n The UK Joint Committee on Vaccination and Immunisation has recommended the use of adjuvanted injectable vaccine for those people aged \u2265\u200965 years from season 2018\/19 onwards. A future study will be required to evaluate this vaccine.<\/jats:p>\n <\/jats:sec>\n \n Trial registration<\/jats:title>\n Current Controlled Trials ISRCTN88072400.<\/jats:p>\n <\/jats:sec>\n \n Funding<\/jats:title>\n This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment<\/jats:italic>; Vol. 24, No. 67. See the NIHR Journals Library website for further project information.<\/jats:p>\n <\/jats:sec>","DOI":"10.3310\/hta24670","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T09:37:58Z","timestamp":1606815478000},"page":"1-66","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Vaccine effectiveness of live attenuated and trivalent inactivated influenza vaccination in 2010\/11 to 2015\/16: the SIVE II record linkage study"],"prefix":"10.3310","volume":"24","clinical-trial-number":[{"clinical-trial-number":"isrctn88072400","registry":"10.18810\/isrctn","type":"results"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5194-8083","authenticated-orcid":true,"given":"Colin R","family":"Simpson","sequence":"first","affiliation":[{"name":"School of Health, Faculty of Health, Victoria University of Wellington, Wellington, New Zealand"},{"name":"Asthma UK Centre for Applied Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2707-2779","authenticated-orcid":true,"given":"Nazir I","family":"Lone","sequence":"additional","affiliation":[{"name":"Asthma UK Centre for Applied Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2679-5409","authenticated-orcid":true,"given":"Kim","family":"Kavanagh","sequence":"additional","affiliation":[{"name":"Department of Mathematics and Statistics, University of Strathclyde, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya","family":"Englishby","sequence":"additional","affiliation":[{"name":"Department of Mathematics and Statistics, University of Strathclyde, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6848-5241","authenticated-orcid":true,"given":"Chris","family":"Robertson","sequence":"additional","affiliation":[{"name":"Department of Mathematics and Statistics, University of Strathclyde, Glasgow, UK"},{"name":"Health Protection Scotland, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"McMenamin","sequence":"additional","affiliation":[{"name":"Health Protection Scotland, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrix von","family":"Wissman","sequence":"additional","affiliation":[{"name":"Health Protection Scotland, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleftheria","family":"Vasileiou","sequence":"additional","affiliation":[{"name":"Asthma UK Centre for Applied Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0102-3453","authenticated-orcid":true,"given":"Christopher C","family":"Butler","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"},{"name":"Institute of Primary Care and Public Health, Cardiff University, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lewis D","family":"Ritchie","sequence":"additional","affiliation":[{"name":"Centre of Academic Primary Care, University of Aberdeen, Aberdeen, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9163-492X","authenticated-orcid":true,"given":"Rory","family":"Gunson","sequence":"additional","affiliation":[{"name":"West of Scotland Specialist Virology Centre, Glasgow Royal Infirmary, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6899-748X","authenticated-orcid":true,"given":"J\u00fcrgen","family":"Schwarze","sequence":"additional","affiliation":[{"name":"Child Life and Health, Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7022-3056","authenticated-orcid":true,"given":"Aziz","family":"Sheikh","sequence":"additional","affiliation":[{"name":"Asthma UK Centre for Applied Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6221","published-online":{"date-parts":[[2020,12]]},"reference":[{"key":"key20201127112921054_ref1-bib1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"key20201127112921054_ref1-bib2","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1016\/j.vaccine.2007.03.046","article-title":"The annual impact of seasonal influenza in the US: measuring disease burden and costs","volume":"25","author":"Molinari","year":"2007","journal-title":"Vaccine"},{"key":"key20201127112921054_ref1-bib3","doi-asserted-by":"publisher","first-page":"e014200","DOI":"10.1136\/bmjopen-2016-014200","article-title":"Evaluating the effectiveness, impact and safety of live attenuated and seasonal inactivated influenza vaccination: protocol for the Seasonal Influenza Vaccination Effectiveness II (SIVE II) study","volume":"7","author":"Simpson","year":"2017","journal-title":"BMJ Open"},{"key":"key20201127112921054_ref1-bib4","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/S0140-6736(11)61051-9","article-title":"Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis","volume":"378","author":"Nair","year":"2011","journal-title":"Lancet"},{"key":"key20201127112921054_ref1-bib5","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nature06732","article-title":"Estimating the impact of school closure on influenza transmission from Sentinel data","volume":"452","author":"Cauchemez","year":"2008","journal-title":"Nature"},{"key":"key20201127112921054_ref1-bib6","doi-asserted-by":"publisher","first-page":"e1001527","DOI":"10.1371\/journal.pmed.1001527","article-title":"Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study","volume":"10","author":"Baguelin","year":"2013","journal-title":"PLOS Med"},{"key":"key20201127112921054_ref1-bib7","unstructured":"Department of Health and Social Care. CVI Statement on the Routine Annual Influenza Vaccination Programme. London: Department of Health and Social Care. URL: www.gov.uk\/government\/publications\/jcvi-statement-on-the-routine-annual-influenza-vaccination-programme (accessed 17 June 2015)."},{"key":"key20201127112921054_ref1-bib8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"key20201127112921054_ref1-bib9","doi-asserted-by":"publisher","first-page":"CD004879","DOI":"10.1002\/14651858.CD004879.pub4","article-title":"Vaccines for preventing influenza in healthy children","volume":"8","author":"Jefferson","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"key20201127112921054_ref1-bib10","doi-asserted-by":"publisher","first-page":"CD001269","DOI":"10.1002\/14651858.CD001269.pub4","article-title":"Vaccines for preventing influenza in healthy adults","volume":"7","author":"Jefferson","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"key20201127112921054_ref1-bib11","doi-asserted-by":"publisher","first-page":"20281","DOI":"10.2807\/ese.17.39.20281-en","article-title":"I-MOVE: a European network to measure the effectiveness of influenza vaccines","volume":"17","author":"Valenciano","year":"2012","journal-title":"Euro Surveill"},{"key":"key20201127112921054_ref1-bib12","doi-asserted-by":"publisher","first-page":"f3037","DOI":"10.1136\/bmj.f3037","article-title":"Influenza: marketing vaccine by marketing disease","volume":"346","author":"Doshi","year":"2013","journal-title":"BMJ"},{"key":"key20201127112921054_ref1-bib13","doi-asserted-by":"publisher","first-page":"ii","DOI":"10.2807\/1560-7917.ES2015.20.8.21043","article-title":"Trivalent inactivated seasonal influenza vaccine effectiveness for the prevention of laboratory confirmed influenza in a Scottish population 2000\u20132009","volume":"20","author":"Simpson","year":"2015","journal-title":"Euro Surveill"},{"key":"key20201127112921054_ref1-bib14","doi-asserted-by":"publisher","first-page":"e28743","DOI":"10.1371\/journal.pone.0028743","article-title":"Assessment of the variability in influenza A(H1N1) vaccine effectiveness estimates dependent on outcome and methodological approach","volume":"6","author":"Kavanagh","year":"2011","journal-title":"PLOS ONE"},{"key":"key20201127112921054_ref1-bib15","doi-asserted-by":"publisher","first-page":"4556","DOI":"10.1016\/j.vaccine.2013.07.056","article-title":"Estimates of influenza vaccine effectiveness in primary care in Scotland vary with clinical or laboratory endpoint and method \u2013 experience across the 2010\/11 season","volume":"31","author":"Kavanagh","year":"2013","journal-title":"Vaccine"},{"key":"key20201127112921054_ref1-bib16","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jaci.2014.12.1925","article-title":"Safety of live attenuated influenza vaccine in atopic children with egg allergy","volume":"136","author":"Turner","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"key20201127112921054_ref1-bib17","doi-asserted-by":"publisher","first-page":"20585","DOI":"10.2807\/1560-7917.ES2013.18.37.20585","article-title":"The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials","volume":"18","author":"De Serres","year":"2013","journal-title":"Euro Surveill"},{"key":"key20201127112921054_ref1-bib18","unstructured":"Information Services Division. Practice Team Information (PTI) Statistics. Edinburgh: National Services Scotland; 2010."},{"key":"key20201127112921054_ref1-bib19","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1136\/bmj.38043.414074.EE","article-title":"Influence of socioeconomic deprivation on the primary care burden and treatment of patients with a diagnosis of heart failure in general practice in Scotland: population-based study","volume":"328","author":"McAlister","year":"2004","journal-title":"BMJ"},{"key":"key20201127112921054_ref1-bib20","first-page":"181","article-title":"Completeness and accuracy of morbidity and repeat prescribing records held on general practice computers in Scotland","volume":"46","author":"Whitelaw","year":"1996","journal-title":"Br J Gen Pract"},{"key":"key20201127112921054_ref1-bib21","volume-title":"Scottish Immunisation & Recall System","author":"Information Services Division"},{"key":"key20201127112921054_ref1-bib22","unstructured":"Health Protection Scotland. Surveillance Data and Systems. Glasgow: Health Protection Scotland. URL: https:\/\/hpspubsrepo.blob.core.windows.net\/hps-website\/nss\/2104\/documents\/1_2012-05-17.pdf (accessed 17 June 2015)."},{"key":"key20201127112921054_ref1-bib23","unstructured":"Information Services Division. NHS Hospital Data Quality: Towards Better Data from Scottish Hospitals. Edinburgh: ISD Publications Scotland; 2007."},{"key":"key20201127112921054_ref1-bib24","first-page":"72","article-title":"The Scottish Record Linkage System","volume":"51","author":"Kendrick","year":"1993","journal-title":"Health Bull"},{"key":"key20201127112921054_ref1-bib25","unstructured":"Scottish Public Health Observatory. Overview of Key Data Sources: ISD Linked Database. Edinburgh: National Services Scotland; 2010."},{"key":"key20201127112921054_ref1-bib26","unstructured":"Health Protection Scotland. Influenza Surveillance Systems. Glasgow: Health Protection Scotland. URL: https:\/\/hpspubsrepo.blob.core.windows.net\/hps-website\/nss\/2524\/documents\/1_2009-05-19.pdf (accessed 23 November 2015)."},{"issue":"79","key":"key20201127112921054_ref1-bib27","doi-asserted-by":"publisher","DOI":"10.3310\/hta19790","article-title":"Early estimation of pandemic influenza Antiviral and Vaccine Effectiveness (EAVE): use of a unique community and laboratory national data-linked cohort study","volume":"19","author":"Simpson","year":"2015","journal-title":"Health Technol Assess"},{"key":"key20201127112921054_ref1-bib28","unstructured":"Chief Medical Officer. Seasonal Influenza Vaccination Programme 2015\u201316. Edinburgh: National Services Scotland; 2015."},{"key":"key20201127112921054_ref1-bib29","first-page":"185","volume-title":"Immunisation Against Infections Disease","author":"Salisbury","year":"2006"},{"key":"key20201127112921054_ref1-bib30","doi-asserted-by":"publisher","first-page":"e001019","DOI":"10.1136\/bmjopen-2012-001019","article-title":"Seasonal Influenza Vaccine Effectiveness in the community (SIVE): exploitation of a unique national linked dataset","volume":"15","author":"Lone","year":"2012","journal-title":"BMJ Open"},{"key":"key20201127112921054_ref1-bib31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0163-4453(99)90053-1","article-title":"Influenza diagnosis: from dark isolation into the molecular light. West of Scotland Respiratory Virus Study Group","volume":"39","author":"Wallace","year":"1999","journal-title":"J Infect"},{"key":"key20201127112921054_ref1-bib32","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jcv.2008.08.020","article-title":"Using multiplex real time PCR in order to streamline a routine diagnostic service","volume":"43","author":"Gunson","year":"2008","journal-title":"J Clin Virol"},{"key":"key20201127112921054_ref1-bib33","unstructured":"National Statistics. Scottish Index of Multiple Deprivation: 2009 General Report. Edinburgh: Scottish Government National Statistics Publications; 2009."},{"key":"key20201127112921054_ref1-bib34","unstructured":"Scottish Government. Scottish Government Urban Rural Classification. Edinburgh: Scottish Government. URL: www.gov.scot\/Topics\/Statistics\/About\/Methodology\/UrbanRuralClassification (accessed 14 August 2018)."},{"key":"key20201127112921054_ref1-bib35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"key20201127112921054_ref1-bib36","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/ije\/29.5.891","article-title":"Use of comorbidity scores for control of confounding in studies using administrative databases","volume":"29","author":"Schneeweiss","year":"2000","journal-title":"Int J Epidemiol"},{"key":"key20201127112921054_ref1-bib37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2296-11-1","article-title":"Adaptation and validation of the Charlson Index for Read\/OXMIS coded databases","volume":"11","author":"Khan","year":"2010","journal-title":"BMC Fam Pract"},{"key":"key20201127112921054_ref1-bib38","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1093\/cid\/ciu680","article-title":"Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons","volume":"59","author":"McLean","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key20201127112921054_ref1-bib39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/cid\/ciw176","article-title":"A perfect storm: impact of genomic variation and serial vaccination on low influenza vaccine effectiveness during the 2014\u201315 season","volume":"63","author":"Skowronski","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key20201127112921054_ref1-bib40","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S1473-3099(07)70236-0","article-title":"Mortality benefits of influenza vaccination in elderly people: an ongoing controversy","volume":"7","author":"Simonsen","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"key20201127112921054_ref1-bib41","doi-asserted-by":"publisher","first-page":"948","DOI":"10.2307\/2533848","article-title":"Assessing the sensitivity of regression results to unmeasured confounders in observational studies","volume":"54","author":"Lin","year":"1998","journal-title":"Biometrics"},{"key":"key20201127112921054_ref1-bib42","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1001\/archinternmed.2011.2038","article-title":"Estimating influenza vaccine effectiveness in community-dwelling elderly patients using the instrumental variable analysis method","volume":"172","author":"Wong","year":"2012","journal-title":"Arch Intern Med"},{"key":"key20201127112921054_ref1-bib43","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1093\/ije\/29.4.722","article-title":"An introduction to instrumental variables for epidemiologists","volume":"29","author":"Greenland","year":"2000","journal-title":"Int J Epidemiol"},{"key":"key20201127112921054_ref1-bib44","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.jclinepi.2005.11.012","article-title":"Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations","volume":"59","author":"Glanz","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"key20201127112921054_ref1-bib45","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1016\/j.vaccine.2004.01.017","article-title":"Control without separate controls: evaluation of vaccine safety using case-only methods","volume":"22","author":"Farrington","year":"2004","journal-title":"Vaccine"},{"key":"key20201127112921054_ref1-bib46","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1016\/j.vaccine.2009.01.125","article-title":"Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring","volume":"27","author":"Vellozzi","year":"2009","journal-title":"Vaccine"},{"issue":"10","key":"key20201127112921054_ref1-bib47","doi-asserted-by":"crossref","DOI":"10.3310\/hsdr01100","article-title":"Seasonal Influenza Vaccine Effectiveness (SIVE): an observational retrospective cohort study \u2013 exploitation of a unique community-based national-linked database to determine the effectiveness of the seasonal trivalent influenza vaccine","volume":"1","author":"Simpson","year":"2013","journal-title":"Health Serv Deliv Res"},{"key":"key20201127112921054_ref1-bib48","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S2213-2600(15)00320-3","article-title":"Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study","volume":"3","author":"Kotz","year":"2015","journal-title":"Lancet Respir Med"},{"key":"key20201127112921054_ref1-bib49","unstructured":"Health Protection Scotland. Influenza Surveillance Systems. Glasgow: Health Protection Scotland. URL: www.hps.scot.nhs.uk\/a-to-z-of-topics\/influenza (accessed 1 April 2016)."},{"key":"key20201127112921054_ref1-bib50","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1258\/jrsm.2009.090348","article-title":"Trends in the epidemiology of asthma in England: a national study of 333,294 patients","volume":"103","author":"Simpson","year":"2010","journal-title":"J R Soc Med"},{"key":"key20201127112921054_ref1-bib51","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1136\/jech-2015-207014","article-title":"Factors associated with influenza vaccine uptake during a universal vaccination programme of preschool children in England and Wales: a cohort study","volume":"70","author":"Hardelid","year":"2016","journal-title":"J Epidemiol Community Health"},{"key":"key20201127112921054_ref1-bib52","doi-asserted-by":"publisher","first-page":"7363","DOI":"10.1016\/j.vaccine.2007.08.032","article-title":"Inequalities in uptake of influenza vaccine by deprivation and risk group: time trends analysis","volume":"25","author":"Coupland","year":"2007","journal-title":"Vaccine"},{"key":"key20201127112921054_ref1-bib53","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jinf.2009.04.001","article-title":"Vaccination coverage rates in eleven European countries during two consecutive influenza seasons","volume":"58","author":"Blank","year":"2009","journal-title":"J Infect"},{"key":"key20201127112921054_ref1-bib54","unstructured":"Health Protection Scotland. Monthly National Influenza Report Week Ending 8 May 2016. Glasgow: Health Protection Scotland. URL: www.hps.scot.nhs.uk\/resourcedocument.aspx?id=4356 (accessed 17 June 2018)."},{"key":"key20201127112921054_ref1-bib55","doi-asserted-by":"publisher","first-page":"pii","DOI":"10.2807\/1560-7917.ES.2016.21.38.30348","article-title":"Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015\/16 end-of-season results","volume":"21","author":"Pebody","year":"2016","journal-title":"Euro Surveill"},{"key":"key20201127112921054_ref1-bib56","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1093\/cid\/ciw635","article-title":"2014\u20132015 influenza vaccine effectiveness in the United States by vaccine type","volume":"63","author":"Zimmerman","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key20201127112921054_ref1-bib57","unstructured":"Centers for Disease Control and Prevention (CDC). ACIP Votes Down Use of LAIV for 2016\u20132017 Flu Season. Media Statement. Atlanta, GA: CDC; 2016. URL: www.cdc.gov\/media\/releases\/2016\/s0622-laiv-flu.html (accessed 17 June 2018)."},{"key":"key20201127112921054_ref1-bib58","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S1473-3099(16)00129-8","article-title":"Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies","volume":"16","author":"Belongia","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key20201127112921054_ref1-bib59","doi-asserted-by":"publisher","first-page":"e1006682","DOI":"10.1371\/journal.ppat.1006682","article-title":"A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine","volume":"13","author":"Wu","year":"2017","journal-title":"PLOS Pathog"},{"key":"key20201127112921054_ref1-bib60","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/cid\/ciy097","article-title":"Poor immunogenicity, not vaccine strain egg adaptation, may explain the low H3N2 influenza vaccine effectiveness in 2012\u201313","volume":"67","author":"Cobey","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key20201127112921054_ref1-bib61","volume-title":"Draft Minute of the Meeting on 7 February 2018","author":"Joint Centre for Vaccination and Immunisation"},{"key":"key20201127112921054_ref1-bib62","doi-asserted-by":"publisher","first-page":"e4752","DOI":"10.1136\/bmj.e4752","article-title":"Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study","volume":"345","author":"Braeckman","year":"2012","journal-title":"BMJ"},{"key":"key20201127112921054_ref1-bib63","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1086\/522145","article-title":"Varicella vaccine effectiveness in the US vaccination program: a review","volume":"197","author":"Seward","year":"2008","journal-title":"J Infect Dis"},{"key":"key20201127112921054_ref1-bib64","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1093\/infdis\/jiw047","article-title":"Declining effectiveness of herpes zoster vaccine in adults aged \u226560 years","volume":"213","author":"Tseng","year":"2016","journal-title":"J Infect Dis"},{"issue":"34","key":"key20201127112921054_ref1-bib65","doi-asserted-by":"publisher","DOI":"10.3310\/hta14340-05","article-title":"Vaccine effectiveness in pandemic influenza \u2013 primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine","volume":"14","author":"Simpson","year":"2010","journal-title":"Health Technol Assess"},{"key":"key20201127112921054_ref1-bib66","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S1473-3099(12)70133-0","article-title":"Effectiveness of H1N1 vaccine for the prevention of pandemic influenza in Scotland, UK: a retrospective observational cohort study","volume":"12","author":"Simpson","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"key20201127112921054_ref1-bib67","doi-asserted-by":"publisher","first-page":"20823","DOI":"10.2807\/1560-7917.ES2014.19.22.20823","article-title":"Uptake and impact of a new live attenuated influenza vaccine programme in England: early results of a pilot in primary school-age children, 2013\/14 influenza season","volume":"19","author":"Pebody","year":"2014","journal-title":"Euro Surveill"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2035095","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta24670\/hta24670.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2035095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T15:36:59Z","timestamp":1692113819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/hta24670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":67,"journal-issue":{"issue":"67","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["10.3310\/hta24670"],"URL":"https:\/\/doi.org\/10.3310\/hta24670","relation":{},"ISSN":["1366-5278","2046-4924"],"issn-type":[{"value":"1366-5278","type":"print"},{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"},{"value":"10-2014","name":"contractual_start_date","label":"Contractual start date","group":{"name":"article_history","label":"Article History"}},{"value":"5-2018","name":"editorial_review_begun","label":"Editorial review begun","group":{"name":"article_history","label":"Article History"}},{"value":"11-2018","name":"accepted_for_publication","label":"Accepted for publication","group":{"name":"article_history","label":"Article History"}}]}}